Related Experiment Video
Updated: Mar 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Restenosis after stenting in symptomatic vertebral arterial orifice disease and considerations for better outcome
Jun Young Chang1, Hyun Park2, Oki Kwon3
11 Department of Neurology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.
Insights
Stenting for vertebral artery stenosis can lead to restenosis, particularly with bare metal stents. Abundant cervical collaterals may predict asymptomatic restenosis, influencing revascularization decisions.
Area of Science:
- Vascular Surgery
- Interventional Neurology
- Cardiovascular Research
Background:
- Vertebral artery stenosis can cause vertebrobasilar ischemia.
- Stenting is an option for refractory cases.
- In-stent restenosis is a known complication.
Abstract:
We have performed stenting in 11 patients with symptomatic vertebral arterial orifice stenosis refractory to medical treatment or impairment in anterior circulation. Three of the 11 patients experienced asymptomatic severe in-stent restenosis or occlusion. Bare metal stents were used in those three patients, two of whom received revascularization therapy. Development of sufficient cervical collateral channels reconstituting the distal vertebral artery was the common feature in patients with asymptomatic in-stent restenosis. In selecting appropriate stents, consideration of mechanical strength and drug-eluting properties of a stent according to characteristics of the target vessel is important to reduce the risk of in-stent restenosis. Any decision to perform revascularization should be based on the presence of abundant cervical collaterals as well as clinical symptoms of vertebrobasilar ischemia.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Vascular Spasm
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease I: Introduction
